Table 3.
Treatment Group |
Days Post Instillation |
Protein (mg/mL) |
Total Cells |
---|---|---|---|
PBS/AIN93M | 3 | 0.177 ± 0.007 | 94,269 ± 8,923 |
ITB/AIN93M | 3 | 0.519 ± 0.052* | 168,719 ± 15,343 * |
ITB/0.3%γTmT | 3 | 0.619 ± 0.086* | 127,969 ± 20,720 |
PBS/AIN93M | 8 | 0.185 ± 0.004 | 120,375 ± 9,446 |
ITB/AIN93M | 8 | 1.301 ± 0.157* | 306,807 ± 289,070* |
ITB/0.3%γTmT | 8 | 1.098 ± 0.140* | 329,121 ± 128,784* |
P<0.05 compared to PBS/AIN93M at corresponding duration of exposure.